Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Unicycive Therapeutics Inc
(NQ:
UNCY
)
0.6458
-0.0045 (-0.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Unicycive Therapeutics Inc
< Previous
1
2
Next >
Unicycive to Showcase Pipeline of Innovative Product Candidates at American Society of Nephrology’s Kidney Week 2022
October 26, 2022
From
Unicycive Therapeutics, Inc.
Via
GlobeNewswire
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
October 12, 2022
You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick?
Via
TheNewswire.com
Unicycive Therapeutics to Present at Roth Inaugural Healthcare Opportunities Conference
September 29, 2022
Presentation to Highlight Late-Stage Program in Hyperphosphatemia and Early-Stage Program to Combat Diseases of Mitochondrial Dysfunction
From
Unicycive Therapeutics, Inc.
Via
GlobeNewswire
How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
September 23, 2022
Most people are surprised to learn that chronic kidney disease (CKD) is the fastest growing, non-communicable disease in the United States. 37 million American adults have CKD and more than 600,000...
Via
TheNewswire.com
Exposures
Product Safety
CEO Clip Video Highlights How Unicycive Therapeutics is Working to Improve Quality of Life for Patients Suffering from Kidney Diseases
June 29, 2022
Vancouver, British Columbia--(Newsfile Corp. - June 29, 2022) - Business Television (BTV) chats with Shalabh Gupta, M.D., CEO of Unicycive...
Via
Newsfile
Traders News Source Interviews Dr. Shalabh Gupta, CEO at Unicycive Therapeutics, Inc.
May 24, 2022
NEW YORK, NY / ACCESSWIRE / May 24, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid cap publicly traded companies recently issued a...
From
Traders News Source
Via
AccessWire
Glancy Prongay & Murray LLP Announces Investigation of Unicycive Therapeutics, Inc.
April 14, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.